Effects of red blood cell transfusion on patients undergoing cardiac surgery in Queensland – a retrospective cohort study

Background: Packed red blood cell (pRBC) transfusion is a relatively safe and mainstay treatment commonly used in cardiac surgical patients. However, there is limited evidence on clinical effects of transfusing blood nearing end-of shelf life that has undergone biochemical changes during storage. Ob...

Full description

Bibliographic Details
Main Authors: Obonyo, NG, Dhanapathy, V, White, N, Sela, DP, Rachakonda, RH, Tunbridge, M, Sim, B, Teo, D, Nadeem, Z, See Hoe, LE, Bassi, GL, Fanning, JP, Tung, J, Suen, JY, Fraser, JF
Format: Journal article
Language:English
Published: BioMed Central 2024
_version_ 1811140374614245376
author Obonyo, NG
Dhanapathy, V
White, N
Sela, DP
Rachakonda, RH
Tunbridge, M
Sim, B
Teo, D
Nadeem, Z
See Hoe, LE
Bassi, GL
Fanning, JP
Tung, J
Suen, JY
Fraser, JF
author_facet Obonyo, NG
Dhanapathy, V
White, N
Sela, DP
Rachakonda, RH
Tunbridge, M
Sim, B
Teo, D
Nadeem, Z
See Hoe, LE
Bassi, GL
Fanning, JP
Tung, J
Suen, JY
Fraser, JF
author_sort Obonyo, NG
collection OXFORD
description Background: Packed red blood cell (pRBC) transfusion is a relatively safe and mainstay treatment commonly used in cardiac surgical patients. However, there is limited evidence on clinical effects of transfusing blood nearing end-of shelf life that has undergone biochemical changes during storage. Objective: To investigate evidence of associations between morbidity/mortality and transfusion of blood near end of shelf-life (> 35 days) in cardiac surgical patients. Methods: Data from the Queensland Health Admitted Patient Data Collection database 2007–2013 was retrospectively analysed. Coronary artery bypass graft and valvular repair patients were included. Multivariable logistic regression was used to examine the effect of pRBC age (< 35 days vs. ≥ 35 days) on in-hospital mortality and morbidity. As secondary analysis, outcomes associated with the number of pRBC units transfused (≤ 4 units vs. ≥ 5 units) were also assessed. Results: A total of 4514 cardiac surgery patients received pRBC transfusion. Of these, 292 (6.5%) received pRBCs ≥ 35 days. No difference in in-hospital mortality or frequency of complications was observed. Transfusion of ≥ 5 units of pRBCs compared to the ≤ 4 units was associated with higher rates of in-hospital mortality (5.6% vs. 1.3%), acute renal failure (17.6% vs. 8%), infection (10% vs. 3.4%), and acute myocardial infarction (9.2% vs. 4.3%). Infection carried an odds ratio of 1.37 between groups (CI = 0.9–2.09; p = 0.14) and stroke/neurological complications, 1.59 (CI = 0.96–2.63; p = 0.07). Conclusion: In cardiac surgery patients, transfusion of pRBCs closer to end of shelf-life was not shown to be associated with significantly increased mortality or morbidity. Dose-dependent differences in adverse outcomes (particularly where units transfused were > 4) were supported.
first_indexed 2024-09-25T04:20:58Z
format Journal article
id oxford-uuid:b61b88fa-211c-447c-8d7d-a8d66658e289
institution University of Oxford
language English
last_indexed 2024-09-25T04:20:58Z
publishDate 2024
publisher BioMed Central
record_format dspace
spelling oxford-uuid:b61b88fa-211c-447c-8d7d-a8d66658e2892024-08-01T19:36:09ZEffects of red blood cell transfusion on patients undergoing cardiac surgery in Queensland – a retrospective cohort studyJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:b61b88fa-211c-447c-8d7d-a8d66658e289EnglishJisc Publications RouterBioMed Central2024Obonyo, NGDhanapathy, VWhite, NSela, DPRachakonda, RHTunbridge, MSim, BTeo, DNadeem, ZSee Hoe, LEBassi, GLFanning, JPTung, JSuen, JYFraser, JFBackground: Packed red blood cell (pRBC) transfusion is a relatively safe and mainstay treatment commonly used in cardiac surgical patients. However, there is limited evidence on clinical effects of transfusing blood nearing end-of shelf life that has undergone biochemical changes during storage. Objective: To investigate evidence of associations between morbidity/mortality and transfusion of blood near end of shelf-life (> 35 days) in cardiac surgical patients. Methods: Data from the Queensland Health Admitted Patient Data Collection database 2007–2013 was retrospectively analysed. Coronary artery bypass graft and valvular repair patients were included. Multivariable logistic regression was used to examine the effect of pRBC age (< 35 days vs. ≥ 35 days) on in-hospital mortality and morbidity. As secondary analysis, outcomes associated with the number of pRBC units transfused (≤ 4 units vs. ≥ 5 units) were also assessed. Results: A total of 4514 cardiac surgery patients received pRBC transfusion. Of these, 292 (6.5%) received pRBCs ≥ 35 days. No difference in in-hospital mortality or frequency of complications was observed. Transfusion of ≥ 5 units of pRBCs compared to the ≤ 4 units was associated with higher rates of in-hospital mortality (5.6% vs. 1.3%), acute renal failure (17.6% vs. 8%), infection (10% vs. 3.4%), and acute myocardial infarction (9.2% vs. 4.3%). Infection carried an odds ratio of 1.37 between groups (CI = 0.9–2.09; p = 0.14) and stroke/neurological complications, 1.59 (CI = 0.96–2.63; p = 0.07). Conclusion: In cardiac surgery patients, transfusion of pRBCs closer to end of shelf-life was not shown to be associated with significantly increased mortality or morbidity. Dose-dependent differences in adverse outcomes (particularly where units transfused were > 4) were supported.
spellingShingle Obonyo, NG
Dhanapathy, V
White, N
Sela, DP
Rachakonda, RH
Tunbridge, M
Sim, B
Teo, D
Nadeem, Z
See Hoe, LE
Bassi, GL
Fanning, JP
Tung, J
Suen, JY
Fraser, JF
Effects of red blood cell transfusion on patients undergoing cardiac surgery in Queensland – a retrospective cohort study
title Effects of red blood cell transfusion on patients undergoing cardiac surgery in Queensland – a retrospective cohort study
title_full Effects of red blood cell transfusion on patients undergoing cardiac surgery in Queensland – a retrospective cohort study
title_fullStr Effects of red blood cell transfusion on patients undergoing cardiac surgery in Queensland – a retrospective cohort study
title_full_unstemmed Effects of red blood cell transfusion on patients undergoing cardiac surgery in Queensland – a retrospective cohort study
title_short Effects of red blood cell transfusion on patients undergoing cardiac surgery in Queensland – a retrospective cohort study
title_sort effects of red blood cell transfusion on patients undergoing cardiac surgery in queensland a retrospective cohort study
work_keys_str_mv AT obonyong effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT dhanapathyv effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT whiten effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT seladp effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT rachakondarh effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT tunbridgem effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT simb effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT teod effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT nadeemz effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT seehoele effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT bassigl effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT fanningjp effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT tungj effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT suenjy effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy
AT fraserjf effectsofredbloodcelltransfusiononpatientsundergoingcardiacsurgeryinqueenslandaretrospectivecohortstudy